Monoket Retard en es it fr

Monoket Retard Brand names, Monoket Retard Analogs

Monoket Retard Brand Names Mixture

  • No information avaliable

Monoket Retard Chemical_Formula

C6H9NO6

Monoket Retard RX_link

http://www.rxlist.com/cgi/generic/isomono2.htm

Monoket Retard fda sheet

http://www.fda.gov/cder/foi/anda/98/75-147_Isosorbide.htm

Monoket Retard msds (material safety sheet)

Monoket_Retard MSDS

Monoket Retard Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Monoket Retard Molecular Weight

191.139 g/mol

Monoket Retard Melting Point

88-91oC

Monoket Retard H2O Solubility

1.07E+005 mg/L

Monoket Retard State

Solid

Monoket Retard LogP

-0.15

Monoket Retard Dosage Forms

Tablet (immediate release); Tablet (extended release)

Monoket Retard Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Monoket Retard Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Monoket Retard Absorption

100%

Monoket Retard side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD50=mg/kg(orally in rat)

Monoket Retard Patient Information

Monoket Retard Organisms Affected

Humans and other mammals